As CDC loosens COVID guidelines, Allegheny County transmission rate is medium

The Centers for Disease Control and Prevention made substantive changes to its coronavirus guidance on Aug. 11, citing protections that most Americans have from the virus through vaccinations and boosters or previous infection. The changes include dropping the 6-foot standard in social distancing and the guideline for unvaccinated people without symptoms or a positive test […] The post As CDC loosens COVID guidelines, Allegheny County transmission rate is medium appeared first on PublicSource. PublicSource is a nonprofit news organization serving the Pittsburgh region. Visit to read more.
Picture for As CDC loosens COVID guidelines, Allegheny County transmission rate is medium

COVID-19 in South Dakota: 10 new deaths, hospitalizations over 100

SIOUX FALLS, S.D. (KELO) — The COVID-19 death toll has gone up by 10 in South Dakota from the previous week. According to Wednesday’s update to the South Dakota Department of Health COVID-19 dashboard, 2,973 people have died during the pandemic, up from 2,963 the previous week. The new deaths were seven men and three women in the following age groups: 50-59 (1), 70-79 (4), 80+ (5). New deaths were reported in the following counties: Beadle, Brookings, Brown (2), Clay, Codington, Custer, Minnehaha, Pennington and Perkins.
The Suburban Times

Pierce County COVID-19 data update: Cases, hospitalizations and deaths

Tacoma-Pierce County Health Department announcement. Pierce County remains in Centers for Disease Control and Prevention’s low COVID-19 community level. Our COVID-19 7-day hospitalization rate dropped more than 50% from last week and we’ve seen a drop in case rate as well. At the low level, CDC recommends you:

Todos Medical (OTCMKTS: TOMDF) Interviews Reveal Major Testing Plans

Todos Medical Inc.(OTCMKTS: TOMDF) has been extremely resourceful in the past couple of weeks winning the Monkeypox testing business through a focused customer outreach. On Monday they announced their first two contracts for Monkeypox testing. Proactive Investors did an interview with the CEO and revealed a very deliberate plan of action to have the test validated within a couple of weeks and onboard new and existing customers. Their plan was to canvas the New York and New Jersey locations and get reference agreements from the small testing labs that have the demand but don’t want to scale up the infrastructure for Monkeypox. Todos’ Provista Diagnostics laboratory is highly automated and can accept this kind of demand.

MS Patients Had Strong T-Cell Activation in Response to COVID-19 Vaccination

New research, published in Frontiers in Immunology and conducted by the Tisch Multiple Sclerosis Research Center of New York, suggests that multiple sclerosis (MS) patients receiving anti-CD20 therapy saw strong T-cell activation after receiving two doses of the COVID-19 vaccine. Anti-CD20 therapies cause B-cell depletion, and MS patients receiving these therapies are considered especially vulnerable to COVID-19 due to their lower production of antibodies. This research advances the analysis of T-cell responses, particularly for MS patients, and underscores the larger need to better understand T-cell responses among immunocompromised individuals. Further research advancements may have potential implications for future vaccine designs and applications.

EU eyes autumn approval of Pfizer jab for COVID variants

The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech COVID vaccine adapted for two fast-spreading subvariants of the Omicron strain. Milder but more infectious than earlier types of the COVID virus, the BA.4 and BA.5 types have helped to drive a wave of new cases of the disease in Europe and the United States.

COVID-19 Tests and Cases Tick Up at LincolnHealth

The number of COVID-19 tests performed, the number of positive cases, and the positivity rate all rose during the week of Aug. 1-7, according to LincolnHealth spokesperson John Martins. There were 247 tests performed and 35 positive cases identified in the past week, compared to 218 with 28 positives the...

Vermont officials see a steady rise in tick population

On Monday, Pfizer and French drug maker Valneva announced they are in phase three of developing a vaccine against Lyme disease. The vaccine candidate has been named VLA15 and is the only Lyme disease vaccine in development. It is still being tested for quality, safety, and efficacy. “With increasing global...
MedPage Today

Triple Therapy Continues to Impress in Metastatic NSCLC With High-Risk Mutations

VIENNA -- Patients with non-squamous metastatic non-small cell lung cancer (NSCLC) who had tumor mutations associated with poor prognosis experienced meaningful improvements in survival when treated with a first-line regimen of two immunotherapies plus chemotherapy, a researcher reported. An exploratory analysis from the POSEIDON trial showed a trend for an...

GSK, Sanofi in selloff extending Novavax-led rout

GSK plc (NYSE:GSK) and Sanofi (SNY) (OTCPK:SNYNF) (GCVRX), joint developers of a COVID-19 vaccine, traded sharply lower on Wednesday on above-average volume amid concerns over the disappointing Q2 release from the newest vaccine entrant Novavax (NVAX). With a decline of ~9%, Sanofi (SNY) ADRs have approached a 52-week low while...